查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614087

基於電動車的液態切片市場：按類型、應用和最終用戶分類 - 2025-2030 年全球預測

EV-Based Liquid Biopsy Market by Type (Assay Kits, Instruments, Services), Application (Early Cancer Screening, Recurrence Monitoring, Therapy Selection), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，基於EV的液態切片市場價值為4.0966億美元，預計到2024年將達到4.7312億美元，複合年成長率為15.89%，到2030年將達到11.508億美元。

基於EV的液態切片市場處於醫療診斷的最前沿，重點是分析體液中的細胞外囊泡（EV）以獲得疾病見解，尤其是在腫瘤學、神經病學、感染疾病等領域。這種需求源於對非侵入性診斷工具日益成長的需求，這些工具可以即時了解患者​​的健康狀況，這對於早期診斷和個人化治療計劃至關重要。其應用範圍廣泛，包括癌症檢測、治療效果監測和新型生物標記的發現。最終用戶主要是醫院、診斷實驗室和研究機構。癌症發生率上升和次世代定序(NGS) 技術的進步推動了市場成長，推動了對高精度和高效診斷解決方案的需求。最新的潛在機會在於擴大基於 EV 的液態切片的使用，不僅在腫瘤學領域，而且在心血管和神經退化性疾病領域。透過開發一個可確保高靈敏度和特異性的強大平台，並將其與人工智慧結合，我們可以提高診斷準確性。然而，市場成長受到先進技術高成本、缺乏 EV 分離和分析標準化通訊協定以及嚴格法規結構帶來的臨床實施挑戰等限制因素的阻礙。創新領域包括改進分離技術和增強生物資訊學工具以更好地解釋資料。鼓勵研究和開發重點關注改進分析通訊協定、提高靈敏度和開發具有成本效益的解決方案以提高採用率。該市場的特點是技術進步迅速，主要企業在研發方面投入大量資金以抓住新機會。企業應優先考慮策略聯盟和夥伴關係，以永續地開拓新市場和新技術。總體而言，基於EV的液態切片市場具有巨大的成長潛力，但成功的關鍵在於持續的技術創新和克服監管挑戰，以滿足不斷變化的臨床需求。

主要市場統計
基準年[2023] 40966萬美元
預計年份 [2024] 473.12 百萬美元
預測年份 [2030] 11.508 億美元
複合年成長率（%） 15.89%

市場動態：針對快速發展的基於電動車的液態切片市場揭示的關鍵市場洞察

基於電動車的液態切片市場正在因供需的動態相互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 癌症流行和早期療育的必要性
    • 人們越來越偏好非侵入性診斷方法
  • 市場限制因素
    • 基於EV的液態切片技術成本高
  • 市場機會
    • 基於EV的液態切片方法的進展
    • 政府對液態切片的有利核准
  • 市場挑戰
    • 進行基於 EV 的液態切片的技術併發症

波特五力：駕馭基於 EV 的液態切片市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基於 EV 的液態切片市場的外部影響

外部宏觀環境因素在塑造基於電動車的液態切片市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解基於 EV 的液態切片市場的競爭格局

對基於 EV 的液態切片市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

基於 FPNV 定位矩陣 EV 的液態切片市場供應商績效評估

FPNV定位矩陣是評估基於EV的液態切片市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了基於 EV 的液態切片市場的成功之路

基於 EV 的液態切片市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症盛行率和早期療育的必要性
      • 對非侵入性診斷程序的偏好日益增加
    • 抑制因素
      • 基於EV的液態切片技術高成本
    • 機會
      • 基於 EV 的液態切片程序的進展
      • 政府對液態生物檢體的有利核准
    • 任務
      • 進行基於 EV 的液態切片時的技術問題
  • 市場區隔分析
    • 類型：檢測試劑套件的興起作為臨床診斷的基本標準化方法
    • 最終用戶：學術研究實驗室採用基於 EV 的液態切片進行藥物開發和個人化醫療
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章基於電動車的液態切片市場：按類型

  • 檢測試劑套件
  • 裝置
  • 服務

第7章基於 EV 的液態切片市場：按應用分類

  • 早期癌症篩檢
  • 復發監測
  • 治療方法選擇
  • 治療監測

第8章基於電動車的液態切片市場：按最終用戶分類

  • 學術研究所
  • 臨床實驗室
  • 製藥和生物技術公司

第9章：美洲基於電動車的液態切片市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區基於電動車的液態切片市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲基於EV的液態切片市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Quest Diagnostics 完成對 Haystack Oncology 的收購，將敏感的 MRD液態生物檢體技術添加到癌症診斷產品組合中
    • Agena Bioscience 和 nRichDX 宣佈建立商業合作夥伴關係，共同開發液態生物檢體檢體提取和檢測解決方案
    • Mercy Bioanalytics 在 A 輪資金籌措中籌集了 4,100 萬美元，用於開發用於早期癌症檢測的新 Mercy Halo液態生物檢體平台
  • 戰略分析和建議

公司名單

  • Abcam PLC
  • Agena Bioscience
  • Agilent Technologies, Inc.
  • ALS Automated Lab Solutions GmbH
  • ANGLE PLC
  • Bio-Rad Laboratories, Inc
  • Bio-Techne Corporation
  • BioFluidica
  • Biological Dynamics
  • Bristol-Myers Squibb
  • CH Boehringer Sohn AG & Co. KG
  • Clinomics Europe Ltd.
  • Corning Incorporated
  • ExosomeDx
  • Horiba Ltd.
  • Illumina, Inc.
  • Lonza Group Ltd.
  • Malvern Panalytical Ltd.
  • Mercy BioAnalytics, Inc.
  • MoBiTec GmbH by BIOZOL Diagnostica Vertrieb GmbH
  • Mursla Bio
  • Nanostics Inc.
  • PerkinElmer, Inc.
  • Qiagen NV
  • Quest Diagnostics
  • System Biosciences, LLC
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-2E76C3E47F69

The EV-Based Liquid Biopsy Market was valued at USD 409.66 million in 2023, expected to reach USD 473.12 million in 2024, and is projected to grow at a CAGR of 15.89%, to USD 1,150.80 million by 2030.

The EV-Based Liquid Biopsy market represents a cutting-edge segment in medical diagnostics, focusing on analyzing extracellular vesicles (EVs) from bodily fluids for disease insights, particularly in oncology, neurology, and infectious diseases. Its necessity stems from the increasing demand for non-invasive diagnostic tools that offer real-time insights into patient health, crucial for early diagnosis and personalized treatment plans. The application scope is broad, encompassing cancer detection, monitoring therapeutic efficacy, and uncovering novel biomarkers. End-users primarily include hospitals, diagnostic laboratories, and research institutions. Market growth is fueled by the rising incidence of cancer and advancements in next-generation sequencing (NGS) technologies, propelling the demand for precise and efficient diagnostic solutions. The latest potential opportunities reside in expanding the use of EV-based liquid biopsy beyond oncology to include cardiovascular and neurodegenerative diseases. Developing robust platforms that ensure high sensitivity and specificity, combined with artificial intelligence, could enhance diagnostic accuracy. However, market growth is stymied by limitations such as high costs of advanced technologies, lack of standardized protocols for EV isolation and analysis, and challenges in clinical adoption due to stringent regulatory frameworks. Innovative areas include improving isolation techniques and enhancing bioinformatics tools for better data interpretation. Research is advised to focus on refining analytical protocols, enhancing sensitivity, and developing cost-effective solutions to broaden adoption. The market is characterized by rapid technological advancements and strong competition among key players investing heavily in R&D to capture emerging opportunities. Businesses should prioritize strategic collaborations and partnerships to leverage new markets and emerging technologies sustainably. Overall, the EV-Based Liquid Biopsy market offers substantial growth potential, but success hinges upon overcoming technological and regulatory challenges while continuously innovating to meet evolving clinical needs.

KEY MARKET STATISTICS
Base Year [2023] USD 409.66 million
Estimated Year [2024] USD 473.12 million
Forecast Year [2030] USD 1,150.80 million
CAGR (%) 15.89%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving EV-Based Liquid Biopsy Market

The EV-Based Liquid Biopsy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of cancer and need for early intervention
    • Increasing preference for non-invasive diagnostic procedures
  • Market Restraints
    • High cost of EV-based liquid biopsy technologies
  • Market Opportunities
    • Advancements in EV-based liquid biopsy procedures
    • Favorable government approvals for liquid biopsy
  • Market Challenges
    • Technical complications of performing EV-based liquid biopsy

Porter's Five Forces: A Strategic Tool for Navigating the EV-Based Liquid Biopsy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the EV-Based Liquid Biopsy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the EV-Based Liquid Biopsy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the EV-Based Liquid Biopsy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the EV-Based Liquid Biopsy Market

A detailed market share analysis in the EV-Based Liquid Biopsy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the EV-Based Liquid Biopsy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the EV-Based Liquid Biopsy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the EV-Based Liquid Biopsy Market

A strategic analysis of the EV-Based Liquid Biopsy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the EV-Based Liquid Biopsy Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Agena Bioscience, Agilent Technologies, Inc., ALS Automated Lab Solutions GmbH, ANGLE PLC, Bio-Rad Laboratories, Inc, Bio-Techne Corporation, BioFluidica, Biological Dynamics, Bristol-Myers Squibb, C.H. Boehringer Sohn AG & Co. KG, Clinomics Europe Ltd., Corning Incorporated, ExosomeDx, Horiba Ltd., Illumina, Inc., Lonza Group Ltd., Malvern Panalytical Ltd., Mercy BioAnalytics, Inc., MoBiTec GmbH by BIOZOL Diagnostica Vertrieb GmbH, Mursla Bio, Nanostics Inc., PerkinElmer, Inc., Qiagen N.V., Quest Diagnostics, System Biosciences, LLC, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the EV-Based Liquid Biopsy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Assay Kits, Instruments, and Services.
  • Based on Application, market is studied across Early Cancer Screening, Recurrence Monitoring, Therapy Selection, and Treatment Monitoring.
  • Based on End User, market is studied across Academic & Research Institutes, Clinical Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cancer and need for early intervention
      • 5.1.1.2. Increasing preference for non-invasive diagnostic procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of EV-based liquid biopsy technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in EV-based liquid biopsy procedures
      • 5.1.3.2. Favorable government approvals for liquid biopsy
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complications of performing EV-based liquid biopsy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rise of assay kits as a standardized approach crucial for clinical diagnostics
    • 5.2.2. End User: Adoption of EV-based liquid biopsy in academic and research laboratories for drug development and personalized medicine
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. EV-Based Liquid Biopsy Market, by Type

  • 6.1. Introduction
  • 6.2. Assay Kits
  • 6.3. Instruments
  • 6.4. Services

7. EV-Based Liquid Biopsy Market, by Application

  • 7.1. Introduction
  • 7.2. Early Cancer Screening
  • 7.3. Recurrence Monitoring
  • 7.4. Therapy Selection
  • 7.5. Treatment Monitoring

8. EV-Based Liquid Biopsy Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Clinical Laboratories
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas EV-Based Liquid Biopsy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific EV-Based Liquid Biopsy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa EV-Based Liquid Biopsy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Quest Diagnostics Completes Acquisition of Haystack Oncology, Adding Sensitive MRD Liquid Biopsy Technology to Cancer Diagnostics Portfolio
    • 12.3.2. Agena Bioscience and nRichDX Announce a Commercial Partnership to Create Solutions for the Extraction and Detection of Liquid Biopsy Analytes
    • 12.3.3. Mercy BioAnalytics Raises USD 41 Million in Series A Financing to Advance Novel Mercy Halo Liquid Biopsy Platform for Early Cancer Detection
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC
  • 2. Agena Bioscience
  • 3. Agilent Technologies, Inc.
  • 4. ALS Automated Lab Solutions GmbH
  • 5. ANGLE PLC
  • 6. Bio-Rad Laboratories, Inc
  • 7. Bio-Techne Corporation
  • 8. BioFluidica
  • 9. Biological Dynamics
  • 10. Bristol-Myers Squibb
  • 11. C.H. Boehringer Sohn AG & Co. KG
  • 12. Clinomics Europe Ltd.
  • 13. Corning Incorporated
  • 14. ExosomeDx
  • 15. Horiba Ltd.
  • 16. Illumina, Inc.
  • 17. Lonza Group Ltd.
  • 18. Malvern Panalytical Ltd.
  • 19. Mercy BioAnalytics, Inc.
  • 20. MoBiTec GmbH by BIOZOL Diagnostica Vertrieb GmbH
  • 21. Mursla Bio
  • 22. Nanostics Inc.
  • 23. PerkinElmer, Inc.
  • 24. Qiagen N.V.
  • 25. Quest Diagnostics
  • 26. System Biosciences, LLC
  • 27. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. EV-BASED LIQUID BIOPSY MARKET RESEARCH PROCESS
  • FIGURE 2. EV-BASED LIQUID BIOPSY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EV-BASED LIQUID BIOPSY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EV-BASED LIQUID BIOPSY MARKET DYNAMICS
  • TABLE 7. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY EARLY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY RECURRENCE MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EV-BASED LIQUID BIOPSY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM EV-BASED LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. EV-BASED LIQUID BIOPSY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. EV-BASED LIQUID BIOPSY MARKET, FPNV POSITIONING MATRIX, 2023